3323 Juvenile Polyposis Syndrome Patients Without a Mutation in SMAD4 or BMPR1A: Clinical Presentation and Novel Drivers of Disease

por MacFarland, Suzanne, Ebrahimzadeh, Jessica, Zelley, Kristin, Mamula, Petar, Brodeur, Garrett, Katona, Bryson
Publicado 2019

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma

por Higashi, Mayumi, Kolla, Venkatadri, Iyer, Radhika, Naraparaju, Koumudi, Zhuang, Tiangang, Kolla, Sriharsha, Brodeur, Garrett M.
Publicado 2015

A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model

por Orienti, Isabella, Nguyen, Ferro, Guan, Peng, Kolla, Venkatadri, Calonghi, Natalia, Farruggia, Giovanna, Chorny, Michael, Brodeur, Garrett M
Publicado 2019

Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor

por Orienti, Isabella, Farruggia, Giovanna, Nguyen, Ferro, Guan, Peng, Calonghi, Natalia, Kolla, Venkatadri, Chorny, Michael, Brodeur, Garrett M
Publicado 2020

OR22-02 PTEN Hamartoma Tumor Syndrome in Pediatrics: Triggers for Evaluation and the Value of Surveillance

por Baran, Julia, Tsai, Steven, Singleton, Daniel, Isaza, Amber, Brodeur, Garrett, MacFarland, Suzanne, Zelley, Kristin, Mamula, Petar, Bauer, Andrew Jacob
Publicado 2020

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas

por Naraparaju, Koumudi, Kolla, Venkatadri, Zhuang, Tiangang, Higashi, Mayumi, Iyer, Radhika, Kolla, Sriharsha, Okawa, Erin R., Blobel, Gerd A., Brodeur, Garrett M.
Publicado 2016

Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models

por Alferiev, Ivan S., Guerrero, David T., Soberman, Danielle, Guan, Peng, Nguyen, Ferro, Kolla, Venkatadri, Fishbein, Ilia, Pressly, Blake B., Brodeur, Garrett M., Chorny, Michael
Publicado 2022

Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance

por Alferiev, Ivan S., Guerrero, David T., Guan, Peng, Nguyen, Ferro, Kolla, Venkatadri, Soberman, Danielle, Pressly, Benjamin B., Fishbein, Ilia, Brodeur, Garrett M., Chorny, Michael
Publicado 2022

Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin Lymphoma

por Henrickson, Sarah E., Dolan, Joseph G., Forbes, Lisa R., Vargas-Hernández, Alexander, Nishimura, Shiho, Okada, Satoshi, Kersun, Leslie S., Brodeur, Garrett M., Heimall, Jennifer R.
Publicado 2019

CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas

por Fujita, Tomoyuki, Igarashi, Jun, Okawa, Erin R., Gotoh, Takahiro, Manne, Jayanthi, Kolla, Venkatadri, Kim, Jessica, Zhao, Huaqing, Pawel, Bruce R., London, Wendy B., Maris, John M., White, Peter S., Brodeur, Garrett M.
Publicado 2008

DICER1 RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer

por Ricarte-Filho, Julio C., Casado-Medrano, Victoria, Reichenberger, Erin, Spangler, Zachary, Scheerer, Michele, Isaza, Amber, Baran, Julia, Patel, Tasleema, MacFarland, Suzanne P., Brodeur, Garrett M., Stewart, Douglas R., Baloch, Zubair, Bauer, Andrew J., Wasserman, Jonathan D., Franco, Aime T.
Publicado 2023